All Curated Mutation Sites in HBV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All

BCP

Core Promoter

Core Upstream Regulatory Sequence

Keyword: HBV-HIV Coinfection-19178592

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	19178592	A194T	RT	P	HBV-HIV Coinfection	D C L	View
2	19178592	L180M	RT	P	HBV-HIV Coinfection	D C L	View
3	19178592	M204V	RT	P	HBV-HIV Coinfection	D C L	View
4	19178592	C256G	P	P	HBV-HIV Coinfection	C L	View
5	19178592	F122S	P	P	HBV-HIV Coinfection	C L	View
6	19178592	H126P	P	P	HBV-HIV Coinfection	C L	View
7	19178592	I53A	P	P	HBV-HIV Coinfection	C L	View
8	19178592	I53T	P	P	HBV-HIV Coinfection	C L	View
9	19178592	I53V	P	P	HBV-HIV Coinfection	C L	View
10	19178592	L157M	P	P	HBV-HIV Coinfection	C L	View
11	19178592	R120K	P	P	HBV-HIV Coinfection	C L	View
12	19178592	R18K	P	P	HBV-HIV Coinfection	C L	View
13	19178592	S135Y	P	P	HBV-HIV Coinfection	C L	View
14	19178592	S159T	P	P	HBV-HIV Coinfection	C L	View
15	19178592	S74F	P	P	HBV-HIV Coinfection	C L	View
16	19178592	W243G	P	P	HBV-HIV Coinfection	C L	View
17	19178592	W243W	P	P	HBV-HIV Coinfection	C L	View

Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.